Shares of other companies:
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
Wall Street Lunch: Big Tech Bearishness?
April 22, 2024
Apple Should Climb The Wall Of Worry
April 20, 2024
Microsoft Q3 Preview: Focusing On Copilot
April 19, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
CRL Stock News and Mentions of Charles River Laboratories International, Inc. Stocktwits
Updated: April 23, 2024 (10:18)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Charles River Laboratories International Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Charles River Laboratories International, Inc. (CRL).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Charles River Laboratories International stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Charles River Laboratories International, Inc. (CRL)
April 22, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In Article Trend: Bullish
April 16, 2024 (21:31) / "PR Newswire" (by LLP)
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering market growth.
In Article Trend: Somewhat-Bullish
April 16, 2024 (15:50) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Charles River ( CRL ) Stock Now
Investors are optimistic about Charles River (CRL) owing to strength in RMS and DSA segments.
In Article Trend: Somewhat-Bullish
April 12, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
ICLR or CRL: Which Is the Better Value Stock Right Now?
ICLR vs. CRL: Which Stock Is the Better Value Option?
In Article Trend: Bullish
April 11, 2024 (13:10) / "Zacks Commentary" (by Zacks Equity Research)
Charles River ( CRL ) Forges Collaboration With Ship of Theseus
Charles River (CRL) is set to perform plasmid production for Ship of Theseus.
In Article Trend: Somewhat-Bullish
April 3, 2024 (01:00) / "Benzinga" (by Globe Newswire)
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Charles River ( NYSE:CRL )
NEW YORK, April 02, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, Inc.
In Article Trend: Neutral
March 27, 2024 (20:01) / "PR Newswire" (by DURECT Corporation)
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Earnings Call Today, March 27th at 4:30 p.m. ET
In Article Trend: Neutral
March 26, 2024 (13:39) / "Zacks Commentary" (by Zacks Equity Research)
Charles River ( CRL ) Extends Gene Therapy Deal With NUS Medicine
Charles River (CRL) announces the extension of the gene therapy manufacturing alliance with NUS Medicine.
In Article Trend: Somewhat-Bullish
March 15, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Charles River ( CRL ) Up 6.2% Since Last Earnings Report?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 15, 2024 (14:30) / "Zacks Commentary" (by Zacks Equity Research)
Charles River ( CRL ) Extends Gene Therapy Offering With New Pact
Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
In Article Trend: Neutral
March 14, 2024 (13:46) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Charles River ( CRL ) Stock Now
Investors remain optimistic about Charles River (CRL) due to the strength of the RMS segment.
In Article Trend: Somewhat-Bullish
March 13, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Global In Vitro Toxicology Testing Market Size is projected to reach USD 28.19 billion by 2031, growing at a CAGR of 10.8%: Straits Research
New York, United States, March 13, 2024 ( GLOBE NEWSWIRE ) -- In Vitro toxicology testing is used to determine the toxicity of a substance on non-living cells or tissues. It is a crucial component of preclinical safety evaluation in the pharmaceutical, chemical, and regulatory industries.
In Article Trend: Somewhat-Bullish
March 7, 2024 (12:13) / "Benzinga" (by Globe Newswire)
Veterinary CRO & CDMO Market is expected to Grow with a CAGR of 9.6% from 2024 to 2031
Jersey City, NJ, March 07, 2024 ( GLOBE NEWSWIRE ) -- InsightAce Analytic Pvt.
In Article Trend: Somewhat-Bullish
March 7, 2024 (10:51) / "Benzinga" (by Globe Newswire)
Omics-Based Clinical Trials Market to Reach USD 54.42 Billion to 2031 | InsightAce Analytic
Jersey City, NJ, March 07, 2024 ( GLOBE NEWSWIRE ) -- InsightAce Analytic Pvt.
In Article Trend: Somewhat-Bullish
March 4, 2024 (12:35) / "Benzinga" (by Globe Newswire)
Global Drug Discovery Outsourcing Market Size is Estimated to Reach USD 6370 million by 2030, Growing at a CAGR of 7.6%: Straits Research
New York, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- Outsourcing drug development is a method for discovering novel drugs or therapies in several pharmaceutical, pharmacology, and biochemistry domains. In addition, outsourcing drug discovery initiates the medication development process.
In Article Trend: Somewhat-Bullish
March 2, 2024 (00:48) / "PR Newswire"
Biopharmaceutical Analytical Testing Services Market size to grow by USD 3.45 billion from 2022 to 2027, North ... - PR Newswire
Biopharmaceutical Analytical Testing Services Market size to grow by USD 3.45 billion from 2022 to 2027, North ... PR ...
In Article Trend: Somewhat-Bullish
February 29, 2024 (18:08) / "PR Newswire" (by Elanco Animal Health)
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor
In Article Trend: Somewhat-Bullish
February 26, 2024 (13:41) / "Zacks Commentary" (by Zacks Equity Research)
Charles River ( CRL ) Forges Collaboration With Wheeler Bio
Charles River (CRL) and Wheeler Bio join forces to accelerate the journey from discovery and CMC development to manufacturing.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website